Zimmer Biomet Holdings (ZBH) Income from Non-Controlling Interests (2011 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Income from Non-Controlling Interests of $200000.0 for Q1 2026, down 66.67% year-over-year from $600000.0 in Q1 2025, and up 113.33% quarter-over-quarter from -$1.5 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Income from Non-Controlling Interests (2011 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Income from Non-Controlling Interests history runs 16 years deep, the most recent figure standing at $200000.0 for Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests fell 66.67% year-over-year to $200000.0; the TTM figure through Mar 2026 stood at -$400000.0 (down 122.22% YoY), while the FY2025 annual figure was -$100000.0, down 106.67% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $200000.0, up from -$1.5 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $700000.0 in Q4 2024, with the low at -$1.5 million in Q4 2025.
- The 5-year median for Income from Non-Controlling Interests is $300000.0 (2022), against an average of $229411.8.
- The sharpest annual moves came in 2022 and 2025: Income from Non-Controlling Interests jumped 200.0% in 2022, then slumped 314.29% in 2025.
- Zimmer Biomet Holdings' Income from Non-Controlling Interests stood at $300000.0 in 2022, then soared by 66.67% to $500000.0 in 2023, then jumped by 40.0% to $700000.0 in 2024, then sank by 314.29% to -$1.5 million in 2025, then jumped by 113.33% to $200000.0 in 2026.
- Business Quant data shows ZBH's Income from Non-Controlling Interests at $200000.0 in Q1 2026, -$1.5 million in Q4 2025, and $300000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 900,000.00 |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.30 Mn |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | -1.50 Mn |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 200,000.00 |